Clear All

Showing results 241-250 / 1232

Maurits van Tol to join as Chief Technology Officer

Maurits van Tol to join JM as Chief Technology Officer

Explore

Johnson Matthey announces sale of Health

Johnson Matthey announces the sale of its Health business to Altaris Capital Partners

Explore

First commercial airline flight using 100% drop-in SAF enabled by technology from Virent and Johnson Matthey

News

Explore

Johnson Matthey invests in Fine Chemicals with expanded facility in Cambridge, UK

The investment allows us to work more closely with our customers and create strong partnerships in the Pharma and Biotech industries

Explore

Introducing HTX™ wire: the latest in thermocouple technology

Ritesh Rawal, Research Group Leader and Les Hutton, Product Specialist, presented JM’s latest innovative product in the field of thermocouples at the 2nd Thermocouple Users and Manufacturers Workshop.

Explore

Johnson Matthey wins Innovative Product of the Year at the IChemE Awards

Our joint win with Cardiff University recognises the development of a mercury-free catalyst to support a more environmentally friendly method of producing PVC

Explore

JM and Rennovia announce licence agreement with ADM for glucaric acid production technology

News: We have signed a licence agreement with Archer Daniels Midland Company alongside Rennovia Inc. for glucaric acid production technology.

Explore

Cambridge University lecture theatre named in JM's honour

News: Long-standing relationship with Cambridge's Department of Chemical Engineering and Biotechnology results in lecture theatre being named 'The Johnson Matthey Lecture Theatre'.

Explore

Larry Pentz to Retire from the Board of Johnson Matthey

After a long and distinguished career, Larry Pentz will retire as an executive director of the company on 31st March 2016

Explore

Dorothy Thompson to Retire from Board

Dorothy will retire from the board with effect from the close of the company’s Annual General Meeting on 20th July 2016

Explore